Free US shipping on orders over $150 USD

Free US shipping on orders over $150 USD

Janera Science
21+ · RESEARCH USE ONLY

Restricted Access

This website is intended strictly for qualified research professionals. All products are sold for in-vitro laboratory research use only and are not intended for human or veterinary use.

Statements have not been evaluated by the U.S. Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease. Janera Science is not a 503A compounding pharmacy or 503B outsourcing facility.

Peptide vs Protein: Where the Line Falls, With Nine Research Compounds as Examples

Peptide vs Protein: Where the Line Falls, With Nine Research Compounds as Examples

Peptide vs protein chain-length scale: GHK-Cu, Semax, Selank, Melanotan II, TB-500, BPC-157, MOTS-c and CJC-1295 sit below the 40 amino acid line, with thymosin beta-4 and GHRH just above it
Peptide vs protein chain-length scale: GHK-Cu, Semax, Selank, Melanotan II, TB-500, BPC-157, MOTS-c and CJC-1295 sit below the 40 amino acid line, with thymosin beta-4 and GHRH just above it
Peptide vs protein chain-length scale: GHK-Cu, Semax, Selank, Melanotan II, TB-500, BPC-157, MOTS-c and CJC-1295 sit below the 40 amino acid line, with thymosin beta-4 and GHRH just above it
Date

Reading Time

8-9 minutes.

A peptide is a short chain of amino acids, and a protein is a longer chain, or several chains, folded into a working three-dimensional shape. Both are built from the same amino acids joined by the same peptide bond, so the difference between a peptide and a protein is one of size and structure. The cut-off depends on who is drawing it: a genetics glossary puts it at about 50 amino acids, and US drug regulation puts it at 40.

All Janera Science compounds are supplied strictly for in-vitro laboratory research use only. They are not for human or veterinary use and have not been evaluated by the FDA.

This guide sets out each definition, explains the terms in between, and then places the nine compounds Janera Science carries on the scale, from a three-residue copper complex to a molecule that is not a peptide at all.

Peptide vs Protein: The Short Answer

Peptides are short amino acid chains, typically 2 to 50 residues long, and proteins are made of one or more longer, folded chains. The National Human Genome Research Institute defines a peptide as a chain "typically 2 to 50" amino acids long, and calls a chain of 51 or more a polypeptide (NHGRI, 2026). Its protein entry describes one or more "long, folded chains of amino acids" (NHGRI, 2026).

The four terms sit on one continuous scale, and each step adds length. The table gives the usual working sizes.

Term

What it is

Typical size

Amino acid

A single building block of peptides and proteins

1 unit

Peptide

Amino acids joined by peptide bonds

2 to about 50 residues

Polypeptide

A longer single chain

51 residues or more

Protein

One or more polypeptide chains folded into a functional structure

Hundreds or thousands of amino acids (MedlinePlus, 2021)

The word "residue" means one amino acid once it sits inside a chain.

What Peptides and Proteins Have in Common

Peptides and proteins share one backbone chemistry: amino acids linked head to tail by amide bonds, which chemists call peptide bonds. Each bond joins the carboxyl group of one amino acid to the amino group of the next, and the carbon to nitrogen link inside that amide group is the peptide bond itself (Britannica, 2026).

Breaking those bonds by hydrolysis runs the process in reverse, producing smaller peptides and finally the individual amino acids (Britannica, 2026). The chemistry is identical at every length, so a 7-residue peptide and a 500-residue protein are written and numbered the same way, from the free amino end (the N-terminus) to the free carboxyl end (the C-terminus).

Our guide to peptide nomenclature explains the one-letter and three-letter codes used to write those sequences.

Where the Line Between Peptide and Protein Falls

No single cut-off is universal: length, folding and regulation each draw the line in a slightly different place. Britannica describes the distinction between a polypeptide and a protein as "imprecise and largely academic", noting that some authorities set the upper limit for a polypeptide at a molecular weight of 10,000, or about 100 amino acids (Britannica, 2026).

Diagram of three ways to draw the peptide vs protein line: chain length puts peptides at 2 to 50 amino acids, folded structure defines a protein as long chains folded into a working shape, and US regulation calls more than 40 amino acids a protein

By chain length

Chain length is the most common working definition. The NHGRI places peptides at 2 to 50 amino acids and anything of 51 or more in the polypeptide range (NHGRI, 2026).

Every research peptide in the table further down sits inside that range, at 3 to 29 residues.

By folded structure

A protein is defined by its fold as much as by its length. The NHGRI describes a protein as one or more "long, folded chains of amino acids", whose sequences are set by the gene that encodes it (NHGRI, 2026).

The narration on the NHGRI protein entry adds that some proteins fold to form enzymes, which carry out the chemical reactions the body depends on (NHGRI, 2026). Short synthetic fragments are often studied alongside the larger proteins they are drawn from.

By US regulation: the 40 amino acid rule

US regulation of biological products uses a sharper line. Under 21 CFR 600.3(h)(6), a protein is "any alpha amino acid polymer with a specific, defined sequence that is greater than 40 amino acids in size" (eCFR, 2026).

The same rule counts chains together. When two or more chains associate as they do in nature, the size is the total across those chains, which is why insulin counts as a protein. Insulin's A chain has 21 residues and its B chain 30, for 51 in total (UniProt, 2026). FDA names insulin among the protein products historically approved as drugs, whose approved applications were deemed to be biologics licenses on 23 March 2020 (FDA, 2024). Insulin products appear on FDA's list of those deemed licenses (FDA, 2020).

Peptide vs Polypeptide

A polypeptide is a single long chain of amino acids, and in the NHGRI glossary the term begins where the peptide range ends, at 51 residues. The same entry describes proteins as being made from one or more polypeptides (NHGRI, 2026).

The prefixes describe size loosely. A dipeptide has two amino acids, an octapeptide eight, an oligopeptide a few and a polypeptide many (Britannica, 2026).

So the usual order, peptide vs polypeptide vs protein, runs from short chain, to long chain, to one or more long chains folded into a working structure. Where a polypeptide ends and a protein begins is the imprecise boundary Britannica describes.

Peptides vs Amino Acids

An amino acid is a single molecule, and a peptide is two or more amino acids joined by peptide bonds. The NHGRI describes amino acids as the fundamental building blocks of proteins and counts 20 different amino acids (NHGRI, 2026).

The order of those building blocks defines each peptide. Two peptides can share the same amino acids in different orders and still be different molecules with different properties.

Where Janera's Compounds Sit on the Line

Eight of the nine compounds Janera Science carries are peptides of 3 to 29 residues, below every protein cut-off, and the ninth, NAD+, is not a peptide at all. The table counts residues and gives the molecular weight PubChem lists where it has a record.

Compound

Residues

Molecular weight

Where it sits

GHK-Cu

3 (Gly-His-Lys, bound to copper)

400.9 g/mol (PubChem, 2026)

Tripeptide

Semax

7

813.9 g/mol (PubChem, 2026)

Heptapeptide

Selank

7

751.9 g/mol (PubChem, 2026)

Heptapeptide

Melanotan II

7, six of them in a ring

1,024.2 g/mol (PubChem, 2026)

Cyclic heptapeptide

TB-500

7 (Ac-LKKTETQ)

889.0 g/mol (PubChem, 2026)

Heptapeptide fragment

BPC-157

15

1,419.5 g/mol (PubChem, 2026)

Pentadecapeptide

MOTS-c

16

2,174.6 g/mol (PubChem, 2026)

Peptide

CJC-1295 (no DAC)

29

No PubChem record

Peptide

NAD+

None

663.4 g/mol (PubChem, 2026)

Dinucleotide, outside the peptide family

Each compound has its own chemistry guide in our research library, covering the full sequence and synthesis. Two of the compounds on this list are useful examples because each has a larger relative on the other side of the line.

Bar chart of chain length for Janera research peptides: GHK-Cu 3, Semax, Selank, Melanotan II and TB-500 7, BPC-157 15, MOTS-c 16 and CJC-1295 no DAC 29 amino acids, all below the 40 amino acid US protein line, with thymosin beta-4 at 43 and GHRH at 44 above it

TB-500 and thymosin beta-4

TB-500 is a synthetic seven-residue fragment: an N-terminally acetylated copy of residues 17 to 23 of a much longer molecule (Drug Testing and Analysis, 2012). That parent, thymosin beta-4, is a single chain of 43 amino acids once its starting methionine is removed (UniProt, 2026).

At 43 residues, thymosin beta-4 sits just above the 40 amino acid regulatory line and below the 50-residue glossary line. The fragment and its parent therefore fall on opposite sides of the US definition, and the two names describe different molecules.

CJC-1295 (no DAC) and growth hormone releasing hormone

CJC-1295 without DAC is a modified form of the first 29 residues of growth hormone releasing hormone, listed in a 2026 review as Mod GRF 1-29 (Frontiers in Endocrinology, 2026). Analytical work describes a peptide marketed as CJC-1295 as a 29 amino acid peptide with a C-terminal amide (Drug Testing and Analysis, 2010), and our CJC-1295 DAC vs no DAC guide explains the difference between the two forms. The full-length human hormone, somatoliberin, is 44 amino acids (UniProt, 2026).

The parent sits above 40 and the 29-residue analogue sits below it, so the same pattern repeats. Truncating a sequence can move a molecule from one category into the other.

NAD+: a dinucleotide on a peptide catalogue

NAD+ (nicotinamide adenine dinucleotide) contains no amino acids. Its structure is two nucleotides joined through their phosphate groups, with the formula C21H27N7O14P2 (PubChem, 2026).

Janera carries it for the same research audience, and our NAD+ chemistry guide covers its structure and redox chemistry.

Why the Distinction Matters for Researchers

For a laboratory, the peptide and protein line decides how a molecule is made and how its quality is reported. Short chains of the length Janera carries are built residue by residue on a resin, a method described in our guide to solid-phase peptide synthesis, and each added residue is another step where a by-product can form.

Size also shapes how purity is reported. For a short peptide, purity is commonly reported by high-performance liquid chromatography (HPLC) as the main peak's share of the material the detector records, and our walkthrough of how to read a peptide COA explains what the purity, quantity and contaminant results on a certificate mean.

Finally, precise naming keeps records clear. A notebook entry that names a fragment by its parent protein, or the reverse, describes a different molecule, so the residue count and sequence belong in the record alongside the product name.

Frequently Asked Questions

What is the difference between a peptide and a protein?

A peptide is a short chain of amino acids, typically 2 to 50 residues, and a protein is made of one or more longer chains folded into a working structure. Both use the same peptide bond, so the difference is size and fold. US regulation sets the line at 40 amino acids (eCFR, 2026).

Is a polypeptide the same as a protein?

A polypeptide is a single long chain, and a protein is one or more polypeptides folded into a functional shape. Many proteins are a single folded polypeptide, so the terms overlap. Britannica calls the distinction "imprecise and largely academic" (Britannica, 2026).

How many amino acids make a protein?

It depends on the definition in use. The NHGRI glossary places chains of 51 or more amino acids in the polypeptide range, without setting a separate protein cut-off (NHGRI, 2026). US regulation of biological products calls any defined alpha amino acid polymer of more than 40 amino acids a protein (eCFR, 2026).

Is insulin a peptide or a protein?

Under US regulation, insulin is a protein. Its two chains hold 21 and 30 residues, giving 51 (UniProt, 2026), and the rule adds chains that associate in nature (eCFR, 2026). In everyday chemistry, insulin is also described as a peptide hormone, the term NCBI Gene uses for it (NCBI, 2020).

Is TB-500 a protein?

No. TB-500 is a seven-residue synthetic peptide fragment of thymosin beta-4. The parent molecule is 43 amino acids long, which places it above the 40 amino acid regulatory line (UniProt, 2026).

Are peptides and amino acids the same thing?

No. An amino acid is a single building block, and a peptide is two or more amino acids joined by peptide bonds. The order of the amino acids in the chain defines which peptide it is.

Key Takeaways

  • Peptides and proteins are built from the same amino acids and the same peptide bond, and they differ in chain length and folded structure.

  • The cut-off depends on the definition: peptides run to about 50 residues in the NHGRI glossary, US biologics regulation calls more than 40 a protein, and some authorities place the upper limit of a polypeptide near 100.

  • Every peptide Janera Science carries falls between 3 and 29 residues, and NAD+ is a dinucleotide outside the peptide family.

  • A fragment and its parent can sit on opposite sides of the line, as TB-500 and thymosin beta-4 do, so record the residue count and sequence along with the name.


Browse the Research Catalogue

Every compound in this guide is listed in the Janera Science shop, and posted certificates are matched to lot numbers on the lab results page.

Further Reading:

BPC-157 vs TB-500 sequences compared: a fifteen-residue proline-rich chain and a seven-residue acetylated lysine-containing fragment
BPC-157 vs TB-500: Structure, Origin, and Published Research Compared
BPC-157 vs TB-500 sequences compared: a fifteen-residue proline-rich chain and a seven-residue acetylated lysine-containing fragment
BPC-157 vs TB-500: Structure, Origin, and Published Research Compared
BPC-157 vs TB-500 sequences compared: a fifteen-residue proline-rich chain and a seven-residue acetylated lysine-containing fragment
BPC-157 vs TB-500: Structure, Origin, and Published Research Compared
Semax vs Selank sequences aligned: Met-Glu-His-Phe and Thr-Lys-Pro-Arg parent sequences followed by an identical Pro-Gly-Pro tail
Semax vs Selank: How the Two Heptapeptides Compare
Semax vs Selank sequences aligned: Met-Glu-His-Phe and Thr-Lys-Pro-Arg parent sequences followed by an identical Pro-Gly-Pro tail
Semax vs Selank: How the Two Heptapeptides Compare
Semax vs Selank sequences aligned: Met-Glu-His-Phe and Thr-Lys-Pro-Arg parent sequences followed by an identical Pro-Gly-Pro tail
Semax vs Selank: How the Two Heptapeptides Compare
Abstract rendering of the NAD+ dinucleotide structure showing two nucleotides joined through a phosphate bridge in blue and white
NAD+ Chemistry: Structure, the Redox Couple, and Why It Is Not a Peptide
Abstract rendering of the NAD+ dinucleotide structure showing two nucleotides joined through a phosphate bridge in blue and white
NAD+ Chemistry: Structure, the Redox Couple, and Why It Is Not a Peptide
Abstract rendering of the NAD+ dinucleotide structure showing two nucleotides joined through a phosphate bridge in blue and white
NAD+ Chemistry: Structure, the Redox Couple, and Why It Is Not a Peptide
Janera Science

Same day shipping on US orders received before 2pm PST on weekdays.

© 2026. All rights reserved. Janera Science

Research Use Only — FDA Disclaimer

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products offered by Janera Science are intended strictly for laboratory research use only. They are not intended for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease.

Janera Science is a chemical supplier and does not operate as a compounding pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor as an outsourcing facility under Section 503B of the same Act.

All products are sold solely for in-vitro laboratory research and pre-clinical investigational purposes. By purchasing from Janera Science, the customer represents that they are a qualified professional with the knowledge, equipment, and facilities required to safely handle and use research chemicals, and that they understand and accept the inherent risks associated with laboratory materials.

Janera Science

Same day shipping on US orders received before 2pm PST on weekdays.

© 2026. All rights reserved. Janera Science

Research Use Only — FDA Disclaimer

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products offered by Janera Science are intended strictly for laboratory research use only. They are not intended for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease.

Janera Science is a chemical supplier and does not operate as a compounding pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor as an outsourcing facility under Section 503B of the same Act.

All products are sold solely for in-vitro laboratory research and pre-clinical investigational purposes. By purchasing from Janera Science, the customer represents that they are a qualified professional with the knowledge, equipment, and facilities required to safely handle and use research chemicals, and that they understand and accept the inherent risks associated with laboratory materials.

Janera Science

Same day shipping on US orders received before 2pm PST on weekdays.

© 2026. All rights reserved. Janera Science

Research Use Only — FDA Disclaimer

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration. The products offered by Janera Science are intended strictly for laboratory research use only. They are not intended for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease.

Janera Science is a chemical supplier and does not operate as a compounding pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor as an outsourcing facility under Section 503B of the same Act.

All products are sold solely for in-vitro laboratory research and pre-clinical investigational purposes. By purchasing from Janera Science, the customer represents that they are a qualified professional with the knowledge, equipment, and facilities required to safely handle and use research chemicals, and that they understand and accept the inherent risks associated with laboratory materials.